Illumina, Inc. (ILMN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$194.03
+0.55%
Mkt Cap $29.37B
Analyst Ratings
Buy
8
Hold
4
Sell
3
Price Target (71 analysts)
$156.27
Range $122.00 – $200.00
Implied Upside
-19.5%
Consensus $156.27 vs current $194.03